Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
about
Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African AmericansEpigenetic regulation of hematopoietic stem cell agingGenome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chickenEquitoxic doses of 5-azacytidine and 5-aza-2'deoxycytidine induce diverse immediate and overlapping heritable changes in the transcriptomeDysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedureMicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathwayOxidative stress and DNA methylation in prostate cancer.MicroRNAs associated with metastatic prostate cancerCatalog of microRNA seed polymorphisms in vertebratesMicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial functionOverexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathwaysReduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-AThe role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.MicroRNAs in mutagenesis, genomic instability, and DNA repair.Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.Competitive interactions of cancer cells and normal cells via secretory microRNAsSLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease.Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitisThe evolving understanding of microRNA in bladder cancerEndometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by EpigeneticsmiR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.High-Throughput Sequencing Identifies MicroRNAs from Posterior Intestine of Loach (Misgurnus anguillicaudatus) and Their Response to Intestinal Air-Breathing Inhibition.miRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease.Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancerDengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs.Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAsGenome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma.The significance of epigenetic alterations in lung carcinogenesis.miR-126: A novel regulator in colon cancerConcomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survivalPlasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.MicroRNAs as pharmacological targets in endothelial cell function and dysfunction
P2860
Q24600583-3CEDD918-F12B-4BBC-A727-6253D3CC10E8Q27008271-42ED0BA0-3A35-4408-B8A9-775ACE6F2286Q27026054-9E4303FC-572E-469D-964B-7ED938597CCAQ28384038-8CA3728D-1828-4143-A528-44470078A6C9Q28475641-B963D711-B4D2-4435-BC21-F0A341C95919Q33689126-217A75D3-C640-4DC1-8436-EE6AF6F4AC03Q33733659-4714973B-1BCF-40A0-9A12-474E0660337AQ34021985-36EAEC82-3811-4283-99B3-81B86AE782C1Q34042888-E4E12F24-C51B-4074-A96C-14FD3E259F7BQ34150000-C805BF4C-913C-4AF1-B81B-2625609CDFFEQ34382704-6F8CB3AB-72AD-40ED-91D7-AC52989E597AQ34431793-CE3F765E-663F-4D41-9327-3E17654E9E30Q34499539-279DE3DF-929E-4C64-944D-4F48657227E4Q34601157-BE158BB2-A0B0-4539-A83A-3363382D96EEQ34996343-BDF1508B-9D6C-4B0C-9AF0-D3CF558BB4B7Q35060469-1737018B-5588-47A5-BAFB-80F3A51441E7Q35067942-977B1C68-4DD7-4EB6-81DF-4B003B80E5C4Q35171856-878FF7B0-ABE2-434F-ABEC-924229FEF306Q35552809-9354E459-577D-49C1-9D92-16334DD3E8F4Q35620383-CDE456D4-C24C-4682-97EC-76F7F92644AAQ35668889-C02984EF-2B45-4A57-A519-088B4609C2FBQ35695482-B26DC7C7-17D3-434E-942E-0126E45098C7Q35713275-90FDD347-9C47-4A57-8654-7701B156C82AQ35852484-6E782B9F-A9D2-474C-A3BE-3B999CD40832Q35882785-45A6631B-8166-4359-835D-17282D69798FQ35921263-BB2EA401-18C2-4E3E-9D40-3C9719175CF1Q35922377-4EEBD230-1162-48CD-AB75-658A1BD37395Q35942714-B083EEA5-9D02-4E05-9874-196F0C059797Q36166856-2FBC3846-6327-4B3E-AFD0-AAD19893949CQ36280060-4CA411A8-84E9-4C3A-B982-CAA918AA132BQ36294643-B8E1B5AF-9E76-46A5-9D15-A9A571083210Q36326608-29AAB62D-A3B8-4ACD-A454-0663B3B9CBABQ36402751-804AD938-7E59-4AC8-9CE1-415E7F8AFE14Q36457427-50C8695E-C13F-4DE8-8F9A-E2472DD578D1Q36524048-A3FC9A86-CD58-4E1A-AD4B-0A88803845AAQ36718761-896998B5-BC74-4A9C-A8F6-CB3F98E0C8FAQ36746000-D84EA56D-CACD-4F7F-B87C-B2B17AAE26D9Q36820516-A429789B-6CDD-4641-95C6-CB0026FBC180Q36902134-4A3DC868-F75C-49DF-9302-E74760881A5AQ37118124-2D25DF1B-4E7B-4186-BDD5-A9E03E2C9A48
P2860
Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@ast
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@en
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@nl
type
label
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@ast
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@en
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@nl
prefLabel
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@ast
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@en
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@nl
P2093
P1476
Epigenetic therapy upregulates ...... e EGFL7 in human cancer cells.
@en
P2093
Gangning Liang
Gerda Egger
Jeffrey M Friedman
Jody C Chuang
Yoshimasa Saito
Yoshitomo Chihara
P304
P356
10.1016/J.BBRC.2008.12.098
P407
P577
2008-12-29T00:00:00Z